GeneDx Holdings WGS
NASDAQ WGS
$101.10 -3.85 (-3.67%)
At close: Sep 18, 2026 · 4:00 PM EDT

GeneDx Holdings (WGS) Acquisitions (2025)

GeneDx Holdings' (WGS) quarterly Acquisitions came in at -$339000.0 in Q4 2025.

Analysis

GeneDx Holdings (WGS) Acquisitions (2025) Analysis & Trends

GeneDx Holdings (WGS) has reported Acquisitions for 1 consecutive years, with -$339000.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Acquisitions changed N/A year-over-year to -$339000.0 in Q4 2025; TTM through Dec 2025 was -$339000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $32.9 million, changed N/A from the prior year.
  • Acquisitions was -$339000.0 for Q4 2025 at GeneDx Holdings.
  • Over five years, Acquisitions peaked at -$339000.0 in Q4 2025 and troughed at -$339000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn -
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn -
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 225.70 Mn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn -
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn -
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn -
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn -
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn -
10 GeneDx Holdings 3.01 Bn 2.88 Bn 78.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -339,000.00